NEWTON, Mass.--(BUSINESS WIRE)--March 27, 2006--Matritech, Inc. (Amex: MZT) a leading developer and marketer of protein-based diagnostic products for the early detection of cancer, today announced that it has added a Vice President of Sales to its sales and marketing team. David G. Kolasinski, a veteran diagnostic and point-of-care product sales executive with more than 30 years of experience has joined the company. Mr. Kolasinski will be responsible for all non-European sales activities for the company's lead product, the NMP22(R) BladderChek(R) Test, a point-of-care bladder cancer diagnostic test. He will focus initially on accelerating U.S. product sales.
